Grażyna Chodorowska

Grażyna Chodorowska

Auto-generated profile, based on publicly available information

Grażyna Chodorowska

Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, Lublin, Poland

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in Clinica Chimica Acta
Verified
Journal Article
Closed access
APAldona Pietrzak
Aldona Pietrzak
AZAnna Zalewska
Anna Zalewska
GCGrażyna Chodorowska
Grażyna Chodorowska
Dorota KrasowskaDorota Krasowska
Dorota Krasowska
AMAnna Michalak-Stoma
Anna Michalak-Stoma
JRJacek Roliński
Jacek Roliński

20 July 2010 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
APAldona Pietrzak
Aldona Pietrzak
AMAnna Michalak-Stoma
Anna Michalak-Stoma
GCGrażyna Chodorowska
Grażyna Chodorowska
Jacek C. SzepietowskiJacek C. Szepietowski
Jacek C. Szepietowski
Psoriasis is a common disease with the population prevalence ranging from 2% to 3%. Its prevalence in the population is affected by genetic, environmental, viral, infectious, immunological, biochemical, endocrinological, and psychological factors, as well as alcohol and drug abuse. In the recent years, psoriasis has been recognised as a systemic disease associated with numerous multiorgan abnormalities and complications. Dyslipidemia is one of comorbidities in psoriatic patients. Lipid metabolism studies in psoriasis have been started at the beginning of the 20th century and are concentrated on skin surface lipids, stratum corneum lipids and epidermal phospholipids, serum lipids, dermal low-density lipoproteins in the psoriatic skin, lipid metabolism, oxidative stress and correlations between inflammatory parameters, lipid parameters and clinical symptoms of the disease. On the basis of the literature data, psoriasis can be described as an immunometabolic disease.

31 October 2013 in Disease Markers
Verified
Journal Article
Open access
PDF file
AMAnna Michalak-Stoma
Anna Michalak-Stoma
Joanna BartosińskaJoanna Bartosińska
Joanna Bartosińska
MKMałgorzata Kowal
Małgorzata Kowal
MJMaria Juszkiewicz-Borowiec
Maria Juszkiewicz-Borowiec
AGAgnieszka Gerkowicz
Agnieszka Gerkowicz
GCGrażyna Chodorowska
Grażyna Chodorowska
Introduction. Psoriasis is a T cell-mediated inflammatory disease in which pathogenesis T helper (Th) lymphocytes (Th1, Th17, and Th22) play an important role. The aim of the study was to assess the serum levels of some cytokines involved in the Th17 and Th22 responses in psoriatic patients.Material and Methods. The study comprised 60 psoriatic patients and 30 healthy controls. In the serum collected from psoriatic patients and healthy controls, the concentrations of IL-6, IL-12, IL-17, IL-20, IL-22, and IL-23 were examined with ELISA kits. Severity of psoriatic skin lesions was assessed by means of PASI, BSA, and PGA scores.Results. IL-6, IL-20, and IL-22 concentrations were significantly higher in psoriatic patients in comparison with the control group. The positive correlations between the concentrations of IL-22 and IL-20 and severity of psoriasis assessed with PASI and BSA scores as well as IL-17 and PASI score were found. There was also a positive correlation between IL-23 and IL-17 concentrations.Conclusions. Results of the conducted studies suggest that Th22 response may contribute to the skin and systemic inflammatory disease in psoriasis. It seems that early identification of soluble biomarkers and initiation of well-matched treatment may prevent exacerbation and progression of psoriasis.

29 March 2012 in Archives of Dermatological Research
Verified
Journal Article
Open access
PDF file
Konrad JanowskiKonrad Janowski
Konrad Janowski
SSStanisława Steuden
Stanisława Steuden
APAldona Pietrzak
Aldona Pietrzak
Dorota KrasowskaDorota Krasowska
Dorota Krasowska
ŁKŁukasz Kaczmarek
Łukasz Kaczmarek
GCGrażyna Chodorowska
Grażyna Chodorowska
Social support was shown to be an important factor buffering negative effects of stress in a range of clinical populations. Little is known, however, about the role of social support in the population of patients with psoriasis although strong psychosocial stress has been implicated in this disease. The objective of this study was to evaluate the association between social support and selected indices of adaptation to life with the disease, including health-related quality of life, depressive symptoms and acceptance of life with the disease, in a sample of patients with psoriasis. Additionally, gender differences in these relationships were analyzed. One-hundred-four patients with psoriasis completed psychological tests measuring disease-related social support, health-related quality of life, depressive symptoms and acceptance of life with the disease. Psoriasis severity was assessed by Psoriasis Area and Severity Index. The patients reporting higher social support levels had significantly higher quality of life, lower depression levels, and higher acceptance of life with the disease. The strengths of these effects, however, were different in women and men. Higher social support was slightly more closely associated with better acceptance of life with the disease in men than in women. However, higher social support was more closely associated to lower depression and better quality of life in women than in men. Among different types of social support, tangible support was found to be the best predictor for the all adaptation indices. Effects of social support perceived by psoriasis patients on adaptation to the disease may be gender-related and exact pathways of these effects may depend on the type on the dimension of social support and the selected type of adaptation indicator. Tangible support seems the most important type of support contributing to better adaptation in both women and men with psoriasis.

19 February 2004 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
GCG Chodorowska
G Chodorowska
DWD Wojnowska
D Wojnowska
MJM Juszkiewicz‐Borowiec
M Juszkiewicz‐Borowiec

1 December 2011 in European Cytokine Network
Verified
Journal Article
Closed access
PDF file
AMAnna Michalak-Stoma
Anna Michalak-Stoma
APAldona Pietrzak
Aldona Pietrzak
Jacek C. SzepietowskiJacek C. Szepietowski
Jacek C. Szepietowski
AZAnna Zalewska-Janowska
Anna Zalewska-Janowska
TPTomasz Paszkowski
Tomasz Paszkowski
GCGrażyna Chodorowska
Grażyna Chodorowska
Psoriasis is a chronic genetically determined, erythemato-squamous disease associated with many comorbidities. Evidence from clinical studies and experimental models support the concept that psoriasis is a T cell-mediated inflammatory skin disease and T helper (Th) cells - Th1, Th17 and Th22 - play an important role in the pathogenesis. Th1 cytokines IFNγ, IL-2, as well as Th17 cytokines IL-17A, IL-17F, IL-22, IL-26, and TNFα (Th1 and Th17 cytokine) are increased in serum and lesional skin. IL-22 produced by Th17 and new subset of T helper cells, Th22, is also increased within psoriatic lesions and in the serum. Other recently recognized cytokines of significant importance in psoriasis are IL-23, IL-20 and IL-15. The IL-23/Th17 pathway plays a dominant role in psoriasis pathogenesis. Currently due to enormous methodological progress, more and more clinical and histopathological psoriatic features could be explained by particular cytokine imbalance, which still is one of the most fascinating dermatological research fields stimulating new and new generations of researchers.